MID-VOLUME · HOSP-HEAVY
granisetron Side Effects
granisetron (also sold as Kytril) sits MID-VOLUME #317 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 48.0% mention hospitalization (4,892 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 10,198
- FAERS reports
FDA Adverse Event Reporting System extract for granisetron. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
granisetron: 48.0% mention hospitalization (4,892 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #317 of 524 by FAERS report count.
Mid-book FAERS page for granisetron (Kytril) (10,198 reports). Signature HOSP-HEAVY. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2003–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
NAUSEA leads 1,305 of 10,198 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (2,620 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (1,855 reports, 18.2%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 601 |
| NAUSEA | 186 |
| DIARRHOEA | 167 |
| PNEUMONIA | 155 |
| VOMITING | 143 |
| FATIGUE | 140 |
| PYREXIA | 135 |
| SEPSIS | 131 |
| DYSPNOEA | 113 |
| FEBRILE NEUTROPENIA | 109 |
| ANAEMIA | 103 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 100 |
| MALIGNANT NEOPLASM PROGRESSION | 100 |
| DISEASE PROGRESSION | 96 |
| DECREASED APPETITE | 92 |
| NEUTROPENIA | 92 |
| THROMBOCYTOPENIA | 88 |
| ASTHENIA | 87 |
| DEHYDRATION | 79 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (4,892, 48.0% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| FEBRILE NEUTROPENIA | 591 |
| NAUSEA | 562 |
| PYREXIA | 501 |
| DIARRHOEA | 447 |
| VOMITING | 433 |
| DYSPNOEA | 315 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 312 |
| ANAEMIA | 305 |
| PNEUMONIA | 283 |
| NEUTROPENIA | 261 |
| FATIGUE | 248 |
| SEPSIS | 196 |
| DECREASED APPETITE | 194 |
| ABDOMINAL PAIN | 190 |
| THROMBOCYTOPENIA | 185 |
| DEHYDRATION | 177 |
| ASTHENIA | 171 |
| PLATELET COUNT DECREASED | 170 |
| CONSTIPATION | 161 |
| HYPOTENSION | 159 |
How to read granisetron FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 10,198 voluntary reports linked to granisetron (Kytril), 2003-2025. Death is listed on 1,855 (18.2%). Hospitalization appears on 4,892 (48.0%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 48.0% mention hospitalization (4,892 reports).
Read with granisetron
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 10,228 FAERS cases (Δ 30 heavier vs granisetron); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 10,232 FAERS cases (Δ 34 heavier vs granisetron); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 10,243 FAERS cases (Δ 45 heavier vs granisetron); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 10,248 FAERS cases (Δ 50 heavier vs granisetron); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 43.9 pp vs granisetron's DEATH-HEAVY): CASELOAD · HOSP-MID.
granisetron stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.